What are the Challenges in Targeting Nuclear Receptors?
While targeting nuclear receptors presents promising therapeutic opportunities, challenges remain. These include the development of resistance to receptor-targeted therapies, the complexity of receptor signaling networks, and the potential for adverse effects due to receptor modulation in non-cancerous tissues. Moreover, some nuclear receptors may have different roles in different types of tissues or stages of cancer, complicating the development of universal therapeutic strategies.
